Browsing: JAK inhibitor

HSA Approves New JAK inhibitor Abrocitinib (Cibinqo) For The Treatment of Atopic Dermatitis

By KayeMay 5, 20220

Atopic dermatitis affects many in Singapore, yet severe cases remain difficult to control. New oral therapies like the JAK-1 inhibitor abrocitinib are expanding treatment options, with trials showing faster itch relief and improved skin clearance for some patients.

Upadacitinib (Rinvoq): Once-Daily Oral Treatment for Rheumatoid Arthritis (RA)

By KayeMarch 17, 20220

About
Advertise
Contact Us
Privacy Policy

About
Advertise
Contact Us
Privacy Policy

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

Prof Poh Kian Keong is Singapore’s Only Recipient of the American College of Cardiology’s 2026 Distinguished Awards

Can You Survive a Week on Instant Noodles Alone?

AAD 2026: Late-Breaking Data Demonstrate Efficacy of Nemolizumab in Children (Aged 2-11) with Moderate-to-Severe Atopic Dermatitis

Browsing: JAK inhibitor

HSA Approves New JAK inhibitor Abrocitinib (Cibinqo) For The Treatment of Atopic Dermatitis

Upadacitinib (Rinvoq): Once-Daily Oral Treatment for Rheumatoid Arthritis (RA)

Prof Poh Kian Keong is Singapore’s Only Recipient of the American College of Cardiology’s 2026 Distinguished Awards

Can You Survive a Week on Instant Noodles Alone?

AAD 2026: Late-Breaking Data Demonstrate Efficacy of Nemolizumab in Children (Aged 2-11) with Moderate-to-Severe Atopic Dermatitis

Signs of Burnout: Why You Are Always Tired and Stressed

Subscribe to Updates

What's Hot

Browsing: JAK inhibitor

Subscribe to Updates